跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14 条关于
“Avram Hershko”
全部
14
临床试验
2
药物
1
机构
5
资讯
6
2个月前
Katalin Karikó Traces mRNA Journey from Discovery to Therapeutic Revolution at 75th Lindau Nobel Laureate Meeting
去年
SEED Therapeutics Receives FDA Clearance for First-in-Human Trial of RBM39 Degrader ST-01156
去年
SEED Therapeutics Appoints Dr. Bill Desmarais as CFO and CBO to Advance Targeted Protein Degradation Pipeline
10个月前
SEED Therapeutics Receives China NMPA Clearance for ST-01156 Molecular Glue Degrader in Rare Cancer Trial
8个月前
SEED Therapeutics Initiates First-in-Human Trial of ST-01156, Novel Molecular Glue Degrader Targeting RBM39
上个月
Schizophrenia's synaptic loss follows the brain's molecular and connectivity architecture, PET study finds